These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis. Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S. Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247 [Abstract] [Full Text] [Related]
26. [Cataracts in patients with chronic renal insufficiency in regular hemodialysis treatment]. Karel I, Stibor V, Lachmanová J, Tomásek R, Straková M. Cesk Oftalmol; 1974 Jul; 30(4):282-6. PubMed ID: 4848207 [No Abstract] [Full Text] [Related]
28. [Hyperprebetalipoproteinemia in patients treated by hemodialysis: clinico-experimental study]. Notarbartolo A, Stalteri A, Averna MR, Picone G, Piovana U, Montalto G, Battianati E, De Simone M. G Clin Med; 1980 May; 61(5):386-401. PubMed ID: 7450358 [No Abstract] [Full Text] [Related]
29. Deep vein thrombosis in end-stage renal disease. Ifudu O, Delaney VB, Barth RH, Friedman EA. ASAIO J; 1994 May; 40(1):103-5. PubMed ID: 8186484 [Abstract] [Full Text] [Related]
30. [Clinical study of picotamide in patients with vascular diseases]. Speziale F, Taurino M, Colella E, Rizzo L, Fiorani P. Recenti Prog Med; 1989 May; 80(5):271-5. PubMed ID: 2762664 [Abstract] [Full Text] [Related]
31. [Hyperlipoproteinemia in patients treated with hemodialysis]. Jeren-Strujić B, Prejac M, Horvatin-Godler S. Acta Med Iugosl; 1985 May; 39(3):217-24. PubMed ID: 4072761 [No Abstract] [Full Text] [Related]
33. [Cutaneous manifestations in uremic patients under periodic hemodialysis therapy]. Aste N, Altieri P, Mulas P, Bolasco PG, Barracca A. Minerva Nefrol; 1983 May; 30(4):217-20. PubMed ID: 6664608 [No Abstract] [Full Text] [Related]
34. Effects of prolonged picotamide therapy on platelet activity in patients with peripheral arterial disease. Danese C, Sergio G, Giunta G, Landi MT, Renzulli C, Panciocco MG, De Rossi MG, Perego MA. Curr Med Res Opin; 1988 May; 11(4):221-6. PubMed ID: 2975203 [Abstract] [Full Text] [Related]
35. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H, Baradaran A. J Ayub Med Coll Abbottabad; 2004 May; 16(2):3-8. PubMed ID: 15455608 [Abstract] [Full Text] [Related]
36. Antiaggregatory effects of picotamide in long-term treatment: a 2-year, double-blind placebo-controlled trial. Cocozza M, Milani M, Picano T, Oliviero U, Russo N, Coto V. Vasc Med; 1997 Nov; 2(4):292-5. PubMed ID: 9575601 [Abstract] [Full Text] [Related]
37. [Disorders of blood coagulation and fibrinolysis in patients with chronic renal failure during treatment with hemodialysis, and methods of correction]. Neĭmark MI. Ter Arkh; 1984 Nov; 56(7):48-53. PubMed ID: 6484834 [No Abstract] [Full Text] [Related]
38. Perforating pseudoxanthoma elasticum associated with chronic renal failure and hemodialysis. Nickoloff BJ, Noodleman FR, Abel EA. Arch Dermatol; 1985 Oct; 121(10):1321-2. PubMed ID: 4037828 [Abstract] [Full Text] [Related]
39. [Hemostasis in patients with chronic kidney failure treated with long-term hemodialysis]. Opatrný K, Cepelák V, Opatrný K. Vnitr Lek; 1988 Sep; 34(9):918-23. PubMed ID: 3201769 [No Abstract] [Full Text] [Related]
40. [The disseminated intravascular coagulation syndrome in patients with chronic renal insufficiency during hemodialysis]. Neĭmark MI. Klin Med (Mosk); 1986 Jun; 64(6):116-22. PubMed ID: 3747425 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]